期刊文献+

HMGB1在不同转归结果的舌癌病理标本中的表达

Expression of HMGB1 in tongue squamous cell carcinoma with different prognosis of diseases
原文传递
导出
摘要 目的:探讨舌鳞癌病理标本中高迁移率族蛋白1(HMGB1)的表达对肿瘤疾病转归的影响。方法:收集资料完整的舌鳞癌患者首次手术病理标本,选择生存期2年以内的病例22例,5年以上的病例10例。采用免疫组织化学染色法观察各标本HMGB1、血管内皮因子(VEGF)的阳性表达及微血管密度,分析比较组间差异。结果:两组不同转归结果的舌癌组织中HMGB1、VEGF阳性表达及微血管密度存在显著差异(P<0.01)。HMGB1表达高的组织有更高的VEGF表达和微血管密度。结论:舌鳞状上皮癌组织中HMGB1的表达与疾病转归有关。HMG1的表达在一定程度上可用作反映舌鳞状上皮癌预后的的重要生物学指标。 Objective:To investigate the expression of high mobility group protein B1(HMGB1) in tongue squamous cell carcinoma and its relation to the prognosis of tumor diseases. Method:Surgical pathology specimen were collected, 22 cases of which survival time less than two years after operation, and 10 cases more than five years.The positive expression of HMGB1 and vascular endothelial factor(VEGF) and microvessel parameters were detected by immunohistochemical staining.Observe the difference between groups. Result:There are significant differences in the positive expression of HMGB1、VEGF and microvessel density in two different outcomes of tongue cancer groups(P〈0.01).high expression of HMGB1 in tongue cancer tissure accompany more high expression of VEGF expression and microvessel density. Conclusion:The expression of HMGB1 in tongue squamous cell carcinoma was related to the prognosis of the disease. HMG1 can be used as an important biological indicator for the prognosis of tongue squamous cell carcinoma.
出处 《临床口腔医学杂志》 2016年第1期23-25,共3页 Journal of Clinical Stomatology
基金 湖北省自然科学基金项目(2014CFC1030)
关键词 高迁移率族蛋白1 舌癌 血管内皮生长因子 微血管密度 High mobility group box-1 protein Tongue squamous cell carcinoma Vascular endothelial growth factor Microvessel density
  • 相关文献

参考文献15

  • 1Andersson U,Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection[J]. Annu Rev Immunol,2011,29:139-162.
  • 2Mattem J,Koomagir,Volmm. Association of vascular endothelial growth factor expression with intratumoral mierovessel density and turnout cell proliferation in human epidermoid lung carcinoma [J]. Br J Cancer,1996,73: 931- 934.
  • 3Weidner N,Seraple JP,Welch WR,et al. Tumou angiogenesis and metastasis-correlation in invasive breast carcinoma [J]. N Engl J MED,1991,324:I-8.
  • 4Mantovania. Cancer: Inflaming metastasis[J]. Nature,2009, 457(7225): 36-37.
  • 5Riuzzi F, Sorci G, Donato R. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo[J]. J Biol Chem,2006,281:8242-8253.
  • 6Zhang Z, Wang M, Zhou L,et al. Increased HMGB1 and cleaved cas- pase-3 stimulate the proliferation of tumor ceils and are correlated with the poor prognosis in colorectal cancer [J]. J Exp Clin Cancer Res,2015,34:51.
  • 7Pusterla T,N~meth J,Stein I,et al. Receptor for advanced glycation endproducts(RAGE) is a key regulator of oval cell activation and in- flammation-associated liver carcinogenesis in mice [J]. Hepatology, 2013,58(1):363-373.
  • 8Harada O,Suga T,Suzuki T,et al. The role of trophinin,an adhesion- molecule unique to human tropholdasts,in progression of colorected cancer [J]. Int J Cancer,2007,121(5):1072-1078.
  • 9Livesey K M, Kang R,Vernon P,et al. p53/HMGB1 complexes regu- late autophagy and apoptosis[J]. Cancer Res, 2012, 72(8):1996-2005.
  • 10Kang R,Tang D,Schapiro NE,et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochon- drial bioenergetics[J]. Oncogene,2014,33:567-577.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部